REQUEST A DEMO
Total
USD $0.00
Search more companies

Farma AD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Farma AD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Farma AD is a company based in Bulgaria, with its head office in Dupnitsa. It operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on 2001. It currently has a total number of 91 (2023) employees. In 2022, the company reported a net sales revenue increase of 59.02%. Over the same period, its total assets grew by 29.34%. Farma AD’s net profit margin increased by 2.65% in 2022.

Headquarters
13 Neofit Rilski Str.
Dupnitsa; Kyustendil; Postal Code: 2600

Contact Details: Purchase the Farma AD report to view the information.

Basic Information
Total Employees:
Purchase the Farma AD report to view the information.
Outstanding Shares:
Purchase the Farma AD report to view the information.
Registered Capital:
Purchase the Farma AD report to view the information.
Incorporation Date:
2001
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
66.9%
Purchase this report to view the information.
31.49%
Purchase this report to view the information.
0.75%
Company Performance
Financial values in the chart are available after Farma AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
59.02%
Total operating revenue
52.35%
Net Profit (Loss) for the Period
72.23%
Total assets
29.34%
Total equity
44.45%
Net Profit Margin
2.65%
Return on Equity (ROE)
8.18%
Quick Ratio
3.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?